H. pylori Infection Often Detected in Patients With Dyspepsia
TUESDAY, May 24, 2022 (HealthDay News) -- In Northwest Ethiopia, 35 percent of patients with dyspepsia have peptic ulcer disease, with risk factors including Helicobacter pylori (H. pylori) infection and nonsteroidal anti-inflammatory drug (NSAID)/acetylsalicylic acid (ASA) use, according to a study published online April 5 in BMC Gastroenterology.
Belete Assefa, from the University of Gondar in Ethiopia, and colleagues conducted an institutional-based cross-sectional study involving 218 dyspeptic patients who underwent upper gastrointestinal endoscopic evaluations to determine the magnitude and associated factors of peptic ulcer disease. Clinical information was obtained using a semistructured questionnaire.
The researchers found that 49 percent of the patients had active H. pylori infection. In 35 percent of patients with dyspepsia, peptic ulcer disease was diagnosed. Risk factors for peptic ulcer disease included H. pylori infection and NSAID/ASA use (adjusted odds ratios, 6.298 and 6.252, respectively).
"Medical treatment of peptic ulcer disease should target treatment of H. pylori infection and cautious use of NSAIDs/ASA," the authors write. "Community-based study is required to conclude the actual findings in the target population."
Related Posts
ACC: Empagliflozin Offers Clinical Benefit in Heart Failure
WEDNESDAY, April 13, 2022 (HealthDay News) -- For patients hospitalized for...
Ticagrelor-Acetylsalicylic Acid More Beneficial for Obese With Minor Stroke, TIA
MONDAY, July 10, 2023 (HealthDay News) -- For patients with minor stroke or...
Prenatal Lifestyle Interventions Improve Child Neurodevelopmental Outcomes
FRIDAY, Aug. 25, 2023 (HealthDay News) -- Maternal structured lifestyle...
El vecindario podría afectar las probabilidades de concepción de una pareja
MIÉRCOLES, 3 de agosto de 2022 (HealthDay News) -- El lugar donde vive podría...